Physician profile
Anna S Graseck
NPI 1578874392
$2,673.67
in general payments reported to CMS, 2019-2025
10 companies · $1,749 in 2025
The $1,749 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.84 · 2021: $11.16 · 2024: $868 · 2025: $1,749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,468 · Food and Beverage: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,468.00 |
| Food and Beverage | $148.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,600.00 | 2025 | |
| Sanofi Pasteur INC. | $868.00 | 2024 | |
| Exeltis, USA INC. | $47.64 | 2025 | Slynd |
| Hologic Sales and Service, LLC | $37.96 | 2019-2021 | |
| Coopersurgical, INC. | $23.62 | 2025 | Paragard T 380a |
| Pfizer INC. | $23.59 | 2025 | |
| Millicent US INC | $20.66 | 2025 | Intrarosa, Femlyv |
| Mayne Pharma Commercial LLC | $19.46 | 2025 | |
| Abbvie INC. | $19.04 | 2019 | |
| Sumitomo Pharma America, INC. | $13.70 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Graseck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.